These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

386 related articles for article (PubMed ID: 34771532)

  • 1. Enhancing T Cell Chemotaxis and Infiltration in Glioblastoma.
    Singh K; Hotchkiss KM; Patel KK; Wilkinson DS; Mohan AA; Cook SL; Sampson JH
    Cancers (Basel); 2021 Oct; 13(21):. PubMed ID: 34771532
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reversing Epigenetic Gene Silencing to Overcome Immune Evasion in CNS Malignancies.
    Ratnam NM; Sonnemann HM; Frederico SC; Chen H; Hutchinson MND; Dowdy T; Reid CM; Jung J; Zhang W; Song H; Zhang M; Davis D; Larion M; Giles AJ; Gilbert MR
    Front Oncol; 2021; 11():719091. PubMed ID: 34336705
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nanoparticle-mediated blockade of CXCL12/CXCR4 signaling enhances glioblastoma immunotherapy: Monitoring early responses with MRI radiomics.
    Wei R; Li J; Lin W; Pang X; Yang H; Lai S; Wei X; Jiang X; Yuan Y; Yang R
    Acta Biomater; 2024 Mar; 177():414-430. PubMed ID: 38360292
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tumor-infiltrating CD8
    Abdoli Shadbad M; Miraki Feriz A; Baradaran B; Safarpour H
    Heliyon; 2024 Mar; 10(5):e27329. PubMed ID: 38495199
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reduction of immunosuppressive tumor microenvironment in cholangiocarcinoma by ex vivo targeting immune checkpoint molecules.
    Zhou G; Sprengers D; Mancham S; Erkens R; Boor PPC; van Beek AA; Doukas M; Noordam L; Campos Carrascosa L; de Ruiter V; van Leeuwen RWF; Polak WG; de Jonge J; Groot Koerkamp B; van Rosmalen B; van Gulik TM; Verheij J; IJzermans JNM; Bruno MJ; Kwekkeboom J
    J Hepatol; 2019 Oct; 71(4):753-762. PubMed ID: 31195061
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CAR-T Therapy for Pediatric High-Grade Gliomas: Peculiarities, Current Investigations and Future Strategies.
    Antonucci L; Canciani G; Mastronuzzi A; Carai A; Del Baldo G; Del Bufalo F
    Front Immunol; 2022; 13():867154. PubMed ID: 35603195
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The CNS and the Brain Tumor Microenvironment: Implications for Glioblastoma Immunotherapy.
    Desland FA; Hormigo A
    Int J Mol Sci; 2020 Oct; 21(19):. PubMed ID: 33027976
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Patient-derived melanoma organoid models facilitate the assessment of immunotherapies.
    Ou L; Liu S; Wang H; Guo Y; Guan L; Shen L; Luo R; Elder DE; Huang AC; Karakousis G; Miura J; Mitchell T; Schuchter L; Amaravadi R; Flowers A; Mou H; Yi F; Guo W; Ko J; Chen Q; Tian B; Herlyn M; Xu X
    EBioMedicine; 2023 Jun; 92():104614. PubMed ID: 37229906
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunotherapy in CNS cancers: the role of immune cell trafficking.
    Ratnam NM; Gilbert MR; Giles AJ
    Neuro Oncol; 2019 Jan; 21(1):37-46. PubMed ID: 29771386
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cocktail strategy for 'cold' tumors therapy via active recruitment of CD8+ T cells and enhancing their function.
    Li X; Luo L; Jiang M; Zhu C; Shi Y; Zhang J; Qin B; Luo Z; Guo X; Lu Y; Shan X; Liu Y; Du Y; Ling P; You J
    J Control Release; 2021 Jun; 334():413-426. PubMed ID: 33964366
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunophenotyping of Newly Diagnosed and Recurrent Glioblastoma Defines Distinct Immune Exhaustion Profiles in Peripheral and Tumor-infiltrating Lymphocytes.
    Mohme M; Schliffke S; Maire CL; Rünger A; Glau L; Mende KC; Matschke J; Gehbauer C; Akyüz N; Zapf S; Holz M; Schaper M; Martens T; Schmidt NO; Peine S; Westphal M; Binder M; Tolosa E; Lamszus K
    Clin Cancer Res; 2018 Sep; 24(17):4187-4200. PubMed ID: 29444930
    [No Abstract]   [Full Text] [Related]  

  • 12. Immune involvement of the contralateral hemisphere in a glioblastoma mouse model.
    Crommentuijn MHW; Schetters STT; Dusoswa SA; Kruijssen LJW; Garcia-Vallejo JJ; van Kooyk Y
    J Immunother Cancer; 2020 Apr; 8(1):. PubMed ID: 32303613
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The immune cell landscape of glioblastoma patients highlights a myeloid-enriched and immune suppressed microenvironment compared to metastatic brain tumors.
    Musca B; Russo MG; Tushe A; Magri S; Battaggia G; Pinton L; Bonaudo C; Della Puppa A; Mandruzzato S
    Front Immunol; 2023; 14():1236824. PubMed ID: 37936683
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Deciphering the Labyrinthine System of the Immune Microenvironment in Recurrent Glioblastoma: Recent Original Advances and Lessons from Clinical Immunotherapeutic Approaches.
    Anghileri E; Patanè M; Di Ianni N; Sambruni I; Maffezzini M; Milani M; Maddaloni L; Pollo B; Eoli M; Pellegatta S
    Cancers (Basel); 2021 Dec; 13(24):. PubMed ID: 34944776
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Soluble factors secreted by glioblastoma cell lines facilitate recruitment, survival, and expansion of regulatory T cells: implications for immunotherapy.
    Crane CA; Ahn BJ; Han SJ; Parsa AT
    Neuro Oncol; 2012 May; 14(5):584-95. PubMed ID: 22406925
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Infiltrating T lymphocytes in the tumor microenvironment of small cell lung cancer: a state of knowledge review.
    Chen Y; Jin Y; Hu X; Chen M
    J Cancer Res Clin Oncol; 2022 Apr; 148(4):881-895. PubMed ID: 34997864
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tertiary Lymphoid Structures in the Central Nervous System: Implications for Glioblastoma.
    van de Walle T; Vaccaro A; Ramachandran M; Pietilä I; Essand M; Dimberg A
    Front Immunol; 2021; 12():724739. PubMed ID: 34539661
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intratumoral IL-12 delivery via mesenchymal stem cells combined with PD-1 blockade leads to long-term antitumor immunity in a mouse glioblastoma model.
    Park J; Park SA; Kim YS; Kim D; Shin S; Lee SH; Jeun SS; Chung YJ; Ahn S
    Biomed Pharmacother; 2024 Apr; 173():115790. PubMed ID: 38431436
    [TBL] [Abstract][Full Text] [Related]  

  • 19. T cells become licensed in the lung to enter the central nervous system.
    Odoardi F; Sie C; Streyl K; Ulaganathan VK; Schläger C; Lodygin D; Heckelsmiller K; Nietfeld W; Ellwart J; Klinkert WE; Lottaz C; Nosov M; Brinkmann V; Spang R; Lehrach H; Vingron M; Wekerle H; Flügel-Koch C; Flügel A
    Nature; 2012 Aug; 488(7413):675-9. PubMed ID: 22914092
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Overcoming cold tumors: a combination strategy of immune checkpoint inhibitors.
    Ouyang P; Wang L; Wu J; Tian Y; Chen C; Li D; Yao Z; Chen R; Xiang G; Gong J; Bao Z
    Front Immunol; 2024; 15():1344272. PubMed ID: 38545114
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.